Institutional Biosafety Committee

The purpose of the Georgetown University Institutional Biosafety Committee (IBC) is to provide regulatory guidance to research personnel to ensure the safe conduct of biomedical research projects, while maintaining compliance with local, state, and federal requirements. Protocol approvals are required for research involving the use of infectious microorganisms, recombinant DNA, and biological toxins. The IBC carries out these functions pursuant to requirements set forth by the National Institutes of Health, and NIH Guidelines For Research Involving Recombinant DNA Molecules. EH&S performs risk assessments to develop biosafety policies and procedures and to set containment levels that ensure the safety of Georgetown University employees and the surrounding community. The IBC serves to provide protocol review and approval, as well as amended protocols. A formal letter is issued to the Principal Investigator and other regulatory stakeholders to document that the committee has approved the research project.

IBC Meetings

IBC meetings will be held on the third Friday of every month. Meetings will be canceled if no new protocols, renewals, or amendments are submitted by the due date of each month.

Protocols that are not submitted on the due date will be reviewed at the next scheduled meeting. The IBC will not review any submission that is not complete and has not addressed edits or clarifications requested by EH&S. These protocols will also be postponed for review to the next month.

IBC Meeting Minutes

In line with NIH Guidelines, Georgetown University posts approved Institutional Biosafety Committee (IBC) meeting minutes from June 1, 2025, forward to ensure transparency in biosafety oversight. Minutes are posted once approved, listed by the month of the meeting. Some months may not have minutes if no meeting took place.

Membership Roster 2024-2025